Material derived from human plasma collected in FDA-licensed facilities and tested in accordance with FDA guidelines for viral markers. The plasma is tested and found non-reactive for HBsAg, anti-HIV1/2, anti-HCV, anti-HBc, anti-HTLV I/II, HIV-1 RNA, HCV RNA, and HBV DNA. Donors are also routinely screened for syphilis negative status prior to donating. The plasma is processed in an FDA-registered, ISO-certified 9001 and 13485 facility and retains lot-to-lot consistency with total protein (>6.0 g/dL), fibrinogen (<25 mg/dL), and cholesterol/triglycerides (<20 mg/dL). Processing includes: • Pooling into batches up to 1,000 Liters • Removal of fibrinogen • Removal of lipids • Charcoal stripped for hormone depletion • 0.2 μm filtered and dialyzed to mimic a serum-like state